Edwards Lifesciences (EW) EPS (Basic) Growth (3y) (2012 - 2025)
Edwards Lifesciences (EW) EPS (Basic) Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 17.98% |
| 10 | Zimmer Biomet Holdings | 19.20 Bn | 18.79 Bn | 1.54 Bn | 1.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58.45% |
| Sep 30, 2025 | -26.12% |
| Jun 30, 2025 | -26.23% |
| Mar 31, 2025 | -26.42% |
| Dec 31, 2024 | -50.37% |
| Sep 30, 2024 | 102.57% |
| Jun 30, 2024 | -87.17% |
| Mar 31, 2024 | -56.92% |
| Dec 31, 2023 | -50.49% |
| Sep 30, 2023 | -46.42% |
| Jun 30, 2023 | 34.88% |
| Mar 31, 2023 | 4.07% |
| Dec 31, 2022 | 12.80% |
| Sep 30, 2022 | 8.01% |
| Jun 30, 2022 | 19.03% |
| Mar 31, 2022 | 14.47% |
| Dec 31, 2021 | 264.00% |
| Sep 30, 2021 | 14.82% |
| Jun 30, 2021 | 20.48% |
| Mar 31, 2021 | 18.32% |